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objectives: We investigated the significance of fibrosis detected by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) 
for the prediction of major clinical events in the pediatric patients with known/suspected cardiomyopathy and their first degree relatives aged <18 
years undergoing family screening.
Background: The role of myocardial fibrosis in the prediction of major clinical events in the pediatric patients with known or suspected 
cardiomyopathy and their first degree relatives aged <18 years undergoing family screening is unknown.
Methods: We assessed the presence of myocardial fibrosis in children undergoing CMR family screening for hypertrophic and dilated 
cardiomyopathies (CM). Some were known to have CM, others were first degree relatives. Patients were followed for the development of morbidity 
and mortality over the median of 272 days (IQR 181-440 days).
results: Among 125 consecutive children (aged 12.9±2.7 years, 53.6% male) seen over 30 months in our CM clinic CMR was diagnostic of dilated 
cardiomyopathy (DCM) in 11 patients and of hypertrophic cardiomyopathy (HCM) in 12 patients. Five of the 13 children in the fibrosis group but 
only 2 of 112 children without fibrosis reached the combined primary end point of cardiovascular death, unplanned cardiovascular admission, 
sustained ventricular tachycardia or ventricular fibrillation or appropriate implantable cardioverter-defibrillator discharge (hazard ratio [HR]: 23.1, 
p=0.0004). In multivariate analysis the presence of myocardial fibrosis remained an independent predictor of major clinical events (HR 18.2, 
p=0.01), but New York Heart Association functional classification and left ventricular ejection fraction did not.
conclusions: In the population of children screened for cardiomyopathy and paediatric patients with suspected cardiomyopathy, myocardial 
fibrosis as measured by late gadolinium enhancement cardiovascular magnetic resonance is an independent predictor of adverse outcome.
